Suppression of transforming growth factor-β results in upregulation of transcription of regeneration factors after chronic liver injury

Suppression of transforming growth factor-β results in upregulation of transcription of regeneration factors after chronic liver injury
复制标题

DOI:
10.1016/j.jhep.2004.08.015
复制
发表时间:
2004-12-01
影响因子:
25.7
通讯作者:
Sata, M
Sata, M
中科院分区:
医学1区
文献类型:
--
作者:
Nakamura, T;Ueno, T;Sata, M

文献摘要

被引文献

相似文献

背景/目标:为探讨显性负性TGF-β受体表达对二甲基亚硝胺(DMN)诱导的大鼠肝损伤后肝再生的影响,采用DMN处理大鼠3周,然后静脉注射AdTbeta-TR、AdLacZ或生理盐水。采用免疫组化和TUNEL法检测肝细胞增殖和凋亡的变化。实时定量PCR和北方印迹法检测肝细胞再生因子(HGF、TGF-α、EGF、IGF-I)和IL-6的mRNA表达。在AdTbeta-TR治疗组中,EGF和IGF-I mRNA表达水平在基因转移后第1天显著升高,并持续3天,TGF-α mRNA表达水平在基因转移后第2 ~ 5天显著升高,HGF mRNA表达水平仅在基因转移后第2天显著上调,而TGF-α mRNA表达水平在基因转移后第3天显著升高。结论:抗TGF-β分子干预治疗DMN诱导的肝损伤大鼠,可促进肝细胞增殖,减少肝细胞凋亡,并上调多种生长因子的转录。(C)2004年欧洲肝脏研究协会。Elsevier B. V.出版,保留所有权利。
Background/Aims: To determine the effects of dominant-negative TGF-beta receptor expression during liver regeneration in rats with dimethylnitrosamine (DMN)-induced liver injury.Methods: Rats were first treated with DMN for 3 weeks, and then intravenously injected once with AdTbeta-TR, AdLacZ, or saline. Serial changes in hepatocyte proliferation and apoptosis were evaluated by immunohistochemistry using anti-Ki67 antibody, and TUNEL staining, respectively. The mRNA expression of regeneration factors (HGF, TGF-alpha, EGF, and IGF-I) and IL-6 were evaluated by real-time PCR and northern blotting.Results: Anti-TGF-beta molecular intervention up-regulated hepatocyte proliferation and inhibited apoptosis. In the AdTbeta-TR-treated rats, EGF and IGF-I mRNA expression levels were significantly increased at day 1 and remained high for 3 days after gene transfer; TGF-alpha mRNA expression levels were significantly increased at 2 to 5 days after gene transfer; HGF mRNA expression levels were significantly up-regulated at day 2 only after gene transfer; while IL-6 mRNA expression level tended to increase at day 1, but decreased thereafter.Conclusions: In rats with DMN-induced liver injury, anti-TGF-beta molecular intervention therapy stimulates proliferation and reduces apoptosis of hepatocytes, and also up-regulates the transcription of various growth factors. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.